PPT-Issues Affecting ART Success: Adherence, ARV Toxicity, Drug Interactions

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents April 2015 AETC NCRC Slide Set 2 July 2016 wwwaidsetcorg About This Presentation These slides were developed using the April 2015 . Meck Chongo, . Virginia . Russell, . Josée. Lavoie, Ross Hoffman, . Mamdouh. . Shubair. University of Northern British Columbia. Agenda. . Background. Objectives . Participants & Research Environment. Bernard Vrijens, PhD. Chief Science Officer, MWV Healthcare. Associate Professor of Biostatistics . University of Liège, Belgium. Adherence is key to therapeutic success. 2. Effective. Disease. Management. Jennifer N. Fosnot, Pharm.D.. Nurse Practitioners Symposium. Nashville, TN. September 27-28. th. , 2012. Objectives. 1.) Discuss the CYP 450 enzymes and common drug interactions with the immunosuppressants. Dr. Naila Abrar. LEARNING OBJECTIVES. By the end of this session you should be able . to: . define . drug . toxicity;. know . the types of . toxicity;. comprehend . the reasons that may lead to toxicity of . Louis Wu, PA-C. Presented at VAPAA Annual Meeting. . March 2, 2017. . Financial Disclosures and Conflicts. I have no financial disclosures nor conflicts concerning this talk. . . Learning Objectives. Dr Shaheen. Delivered By . Dr Naser . Drug interactions- objectives. Discuss Pharmacokinetic interactions. List . Pharmacodynamic. interactions. Comment . on common Drug- Food interactions. Drug interactions. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents . April 2015. AETC . NCRC . Slide Set. 2. July 2016. www.aidsetc.org. About This Presentation. These slides were developed using the April 2015 . H. ome . M. edication Deliverance . Dr. Julianna M Kula, . PharmD. Pediatric Hematology/Oncology/SCT/Investigational Clinical Pharmacist. Lucile Packard Children’s Hospital at Stanford. November 4, 2014. . Department . of Pharmaceutics. 1. 26-Feb-16. Drug interactions . :. . These are said . to occur when the pharmacological activity of a drug is altered by the concomitant use of another drug or by the presence of some other substance. . Drug-Drug Interactions. Basic mechanisms of drug-drug interactions. Clinical significance of drug-drug interactions. Minimizing adverse drug-drug interactions. Drug-Drug Interactions. Interactions can occur whenever a patient takes more than one drug.. & HCV . Therapy. Larry Pineda, . PharmD. , . PhC. , BCPS, AAHIVP. Visiting Assistant Professor. UNM College of Pharmacy. Conflicts of Interest Disclosure. No conflicts of interest. 2. Learning Objectives – Pharmacist. PharmD. UNT System College of Pharmacy. Patrick.Clay@unthsc.edu. O: (817) 735-2798. Originally designed and developed by:. Frank Romanelli, . Pharm.D. ., MPH, BCPS. Professor of Pharmacy, Medicine, & Health Sciences . An Antiretroviral Therapy Review. Sarah Pérez, PharmD, PhC, BCACP, AAHIVP. Disclosure. The speaker has no actual or potential conflicts of interest in relation to this presentation. . Objectives. Pharmacists. Prof JG . Hakim, . Parirenyatwa. . CRS . Leader. Annual Research . Day; 8. th. . April 2016. TB- A Global Problem. TB Transformative Science Group (TB TSG). Agenda. Treatment & prevention of TB with or without HIV co-infection.